Integer Holdings 株価情報 (NYSE: ITGR)

最新ニュース Integer Holdings (NYSE:ITGR) 株価情報

Integer Holdings

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

Integer Holdings Corporation Common Stock

Integer Holdings Corp

Integral

Barclays analyst Julian Mitchell maintains Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with a Equal-Weight and raises the price target from $285 to $300.

News

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Rockwell Automation, Raises Price Target to $300

B of A Securities analyst Jason Gerberry maintains Axsome Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) with a Buy and raises the price target from $143 to $167.

AXSM

B of A Securities Maintains Buy on Axsome Therapeutics, Raises Price Target to $167

B of A Securities analyst Michael McGovern maintains Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Buy and raises the price target from $19 to $21.

LYFT

B of A Securities Maintains Buy on Lyft, Raises Price Target to $21

B of A Securities analyst Sara Senatore maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Neutral and raises the price target from $312 to $316.

B of A Securities Maintains Neutral on McDonald's, Raises Price Target to $316

Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) has outperformed the market over the past 10 years by 6.25% on an annualized basis producing an average annual return of 17.41%. Currently, Texas Roadhouse has a market capitalization of $11.54 billion. 
Buying $100 In TXRH: If an investor had bought $100 of TXRH stock 10 years ago, it would be worth $497.60 today based on a price of $173.05 for TXRH at the time of writing.
<h3>Texas Roadhouse's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739284362_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

TXRH

$100 Invested In Texas Roadhouse 10 Years Ago Would Be Worth This Much Today

STAI

ScanTech AI Management Confirms Company Has No Convertible Or Variable Rate Indebtedness And No Dilutive Equity Structure On Balance Sheet

B of A Securities analyst Robert Ohmes maintains Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) with a Buy and raises the price target from $165 to $185.

B of A Securities Maintains Buy on Sprouts Farmers Market, Raises Price Target to $185

Barclays analyst Ryan Macwilliams maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Overweight and raises the price target from $325 to $360.

MNDY

Barclays Maintains Overweight on Monday.Com, Raises Price Target to $360

Macro Economic Events

Economics

Federal Reserve

Fed's Hammack Says Federal Government Debt Is On Unsustainable Path Over Longer Term; Rate Hike Is Not In My Base Case, Economy In Good Position; Unclear How Much 2024 Rate Cuts Have Factored Into; We May Be Close To Neutral Rate

Biotech

Government

Regulations

General

BBIO

BEYONTTRA Receives European Commission Marketing Authorization For BEYONTTRA For Treatment Of ATTR-CM

B of A Securities analyst Steve Byrne maintains Bunge Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) with a Buy and lowers the price target from $105 to $87.

B of A Securities Maintains Buy on Bunge Global, Lowers Price Target to $87

Barclays analyst Tim Long maintains Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) with a Equal-Weight and lowers the price target from $14 to $10.

HLIT

Barclays Maintains Equal-Weight on Harmonic, Lowers Price Target to $10

Contracts

ESEA

Euroseas Announces 2-Year Charter Contract Extension For Feeder Containership, M/V EM Hydra; For Minimum Period Of 24 Months And Maximum Period Of 26 Months At Gross Daily Rate Of $19,000

B of A Securities analyst Michael Cherny maintains Progyny (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) with a Buy and raises the price target from $21 to $25.

PGNY

B of A Securities Maintains Buy on Progyny, Raises Price Target to $25

B of A Securities analyst Salvator Tiano maintains Archer-Daniels Midland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) with a Underperform and lowers the price target from $54 to $48.

B of A Securities Maintains Underperform on Archer-Daniels Midland, Lowers Price Target to $48

Results demonstrate that CELZ-201 achieved an 80% overall efficacy rate in reducing insulin dependency and stabilizing hemoglobin A1c levels, with no serious adverse effects reported.

CELZ

Creative Medical Technology Reports One-Year Results For AlloStem Type 2 Diabetes Program

Fed's Hammack Says Will Evaluate Trump Economic And Trade Policies As They Come In

Barclays analyst Dan Levy maintains BorgWarner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) with a Overweight and lowers the price target from $43 to $42.

Barclays Maintains Overweight on BorgWarner, Lowers Price Target to $42

B of A Securities analyst Steve Byrne maintains Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) with a Buy and raises the price target from $69 to $73.

CTVA

B of A Securities Maintains Buy on Corteva, Raises Price Target to $73

As of Feb. 11, 2025, two stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Zillow Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>)</h3>
<ul>
<li>On Feb. 5, Benchmark analyst Daniel Kurnos maintained Zillow with a Buy and raised the price target from $80 to $100. The company's stock gained around 25% over the past month and has a <a href="https://www.benzinga.com/quote/ZG">52-week high of $85.89</a>.</li>
<li>RSI Value: 75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ZG Price Action: Shares of Zillow gained 1% to close at $85.29 on Monday.</li>
</ul>
<h3 class="wp-block-heading">Welltower Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>)</h3>
<ul>
<li>On Jan. 29, NorthStar Healthcare Income, Inc. agreed to be acquired by an affiliate of Welltower for $3.03 per share in a $900 million transaction. Nikhil Chaudhri, Co-President and Chief Investment Officer of Welltower said, &#8220;We are delighted to have reached an agreement to acquire NorthStar&#8217;s portfolio of 40 seniors housing communities, which portfolio, subject to satisfaction of closing conditions and closing under the merger agreement, Welltower anticipates will be allocated to an entity affiliated with its recently announced funds management business." The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/WELL">has a 52-week high</a> of $143.84.</li>
<li>RSI Value: 70.8</li>
<li>WELL Price Action: Shares of Welltower gained 0.4% to close at $143.11 on Monday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Markets

WELL

Top 2 Real Estate Stocks You May Want To Dump In February

Integer Holdings (ITGR) has received a new Buy rating, initiated by Wells Fargo analyst, Nathan Treybeck. Nathan Treybeck has given his Buy rating ...

Buy Rating for Integer Holdings (ITGR) Driven by Strong Growth Potential and Strategic Positioning

Citi analyst Joanne Wuensch raised the firm's price target on Integer (ITGR) to $145 from $130 and keeps a Neutral rating on the shares as part of ...

Integer price target raised to $145 from $130 at Citi

Truist analyst Richard Newitter raised the firm's price target on Integer (ITGR) to $163 from $147 and keeps a Buy rating on the shares. The firm i...

Integer price target raised to $163 from $147 at Truist

American Century Small Cap Growth Fund Q3 2024 Commentary

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Integer Holdings (ITGR – Research Report) and Medtro...

Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR) and Medtronic (MDT)

12 Small-cap momentum stocks to watch: MWA, ACA, COMP, and more

KeyBanc raised the firm's price target on Integer (ITGR) to $154 from $144 and keeps an Overweight rating on the shares. The firm believes the back...

Integer price target raised to $154 from $144 at KeyBanc

Integer (ITGR) Holdings will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Con...

Integer to highlight rapid prototyping services at MD&M West 2025

Precision Coating, a Katahdin company, acquired by Integer

Franklin Small Cap Growth Fund Q4 2024 Commentary

ADMA

AGYS

ALGT

AVDX

AZEK

BASE

BOOT

BRBR

BWXT

CAVA

CGJTF

COMP

CWST

FBIN

FRPT

GTLB

ITGR

MMSI

NTRA

OLLI

ONTO

QTWO

SITE

SITM

SONO

STEP

WING

XPRO

XSMO

Earnings

Press Releases

Integer Holdings Corporation Reports Third Quarter 2024 Results

Management

Payman Khales to assume the role of Integer Chief Operating Officer and Andrew Senn to become President, Cardio & Vascular in the first quarter of 2025

Financing

Integer Holdings Corporation Completes Divestiture of Non-Medical Business for $50 Million

Ultralife Corporation Completes Acquisition of Electrochem Solutions, Inc.

Health Care

Integer to Present at Piper Sandler Healthcare Conference on Dec. 3, 2024

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Integer Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 20, 2025

Integer to Highlight Innovations in Neuromodulation, Next Generation of Miniaturized Active Implantable Devices During NANS 2025 Annual Meeting

Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025

Comments

Integer Holdings

ニュース

最新ニュース Integer Holdings (NYSE:ITGR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル